among-people

Statins May Stave Off Liver Cancer in People With Hepatitis B (HealthDay)

HealthDay – THURSDAY, Jan. 26 (HealthDay News) — Popular cholesterol-lowering statins may also lower risk for liver cancer among people with hepatitis B, a new study shows. Hepatitis B, an inflammation of the liver due to the hepatitis B virus, is one of the main causes of liver cancer.

Here is the original post:
Statins May Stave Off Liver Cancer in People With Hepatitis
B
(HealthDay)

among-people

Drug Approved for Advanced Kidney Cancer (HealthDay)

HealthDay – FRIDAY, Jan. 27 (HealthDay News) — Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven’t responded to another drug.

See the original post:
Drug Approved for Advanced Kidney Cancer
(HealthDay)